N.B. In NHSGGC the continuous vancomycin dosing regimen is normally only used in Critical Care wards. Do not use the NHSGGC Adult Vancomycin Intermittent Infusion: Prescribing, Administration and Monitoring (Vanc-PAM) chart for this regimen.
This guideline covers:
To reduce the risk of mortality, commence vancomycin administration within 1 hour of recognising sepsis.
A loading dose is required for all patients who are starting treatment with IV vancomycin. This is followed by a maintenance dose which may be administered either as an intermittent (pulsed) IV infusion or as a continuous IV infusion. For Vancomycin intermittent infusion guideline see here.
Actual body weight | Dose amount | Volume of sodium chloride (0.9%)* | Infusion duration |
<35kg | 25mg/kg | 250ml | 60 minutes per 500mg+ |
35-44kg | 1000mg | 250ml | 2 hours+ |
45-59kg | 1500mg | 500ml | 3 hours+ |
60-89kg | 2000mg | 500ml | 4 hours+ |
90-119kg | 2500mg | 500ml | 5 hours+ |
≥120kg | 3000mg~ |
1000ml Note: See below for fluid restricted patients# |
6 hours+ |
*Glucose 5% may be used in patients with sodium restriction. ~Reconstitute each 1000mg vial with 20mls of water for injection. Withdraw contents of 3x1000mg vials and add to one 1000ml sodium chloride 0.9% infusion bag. Dilute the reconstituted solution to a maximum concentration of 5mg/ml. #Fluid / sodium restricted patients: Reconstitute each 1000mg vial with 20mls water for injection. Withdraw contents of 3x1000mg vials and add to one 500ml sodium chloride 0.9% infusion bag (final concentration approximately 5.4mg/ml)+. +For more information refer to the NHSGGC Vancomycin Adult Intravenous Medicine Monograph (link only active if connected to NHSGGC network). IN CRITICAL CARE AREAS a concentration of up to 10mg/ml may be used (administered via a central line); use of higher concentrations may increase the risk of infusion-related events. For further advice refer to NHSGGC Adult Intravenous Monograph (see link above) or the UKCPA Minimum Infusion Volumes for Fluid Restricted Critically Ill Patients Fourth Edition (see here), or contact pharmacy. |
^For transgender patients (following ≥ 6 months of hormonal gender affirming therapy or at any time after completion of gender affirming surgery) calculate vancomycin dosing and CrCl and ideal body weight (IBW) according to the patient's gender identity. Use the calculators within the GGC Medicines app or via the Staffnet Hub page (link to page only active if connected to NHSGGC network). If gender affirming therapy does not meet the criteria above, use the patient's sex at birth according to their electronic records. The second last digit of a CHI number informs of a patient's assigned sex at birth - for those assigned male it is odd and for those assigned female it is even.
CrCl (ml/minute) | Total Daily dose | Dose for continuous infusion over 12 hours | Volume of sodium chloride 0.9%* for 12-hour infusion~ |
<20 | Use intermittent (pulsed) infusion or follow Renal Unit guidelines | ||
20-25 | 500mg | 250mg | 250ml |
26-34 | 750mg | 375mg | 250ml |
35-49 | 1000mg | 500mg | 250ml |
50-69 | 1500mg | 750mg | 250ml |
70-89 | 2000mg | 1000mg | 250ml |
90-119 | 2500mg | 1250mg | 250ml |
120-180 | 3000mg | 1500mg | 500ml |
>180 | 3750mg | 1875mg | 500ml |
*Glucose 5% may be used in patients with sodium restriction. ~Dilute doses up to 1250mg in 250ml sodium chloride (0.9%) and doses between 1250mg and 2000mg in 500ml sodium chloride 0.9%. For more information refer to the NHSGGC Vancomycin Adult Intravenous Medicine Monograph (link only active if connected to NHSGGC network). FLUID RESTRICTED PATIENTS IN CRITICAL CARE AREAS- refer to the UKCPA Minimum Infusion Volumes For Fluid Restricted Critically Ill Patients Fourth Edition (see here). The final administration concentration should not exceed 5mg/ml for peripheral administration or 10mg/ml for central administration. To avoid the risk of an infusion-related reaction, pain or muscle spasm, administration should be no faster than 500mg/hour unless via a central line in critical care. |
Concentrations are meaningless unless the dose and sample time are recorded accurately |
Monitor creatinine daily. Seek advice if creatinine is unstable (e.g. a change in creatinine of >15-20%).
Take a sample 12-24 hours after starting the continuous infusion then every day with the routine bloods, or as advised by the pharmacist.
Blood sampling for therapeutic drug monitoring (TDM) is not recommended from a vascular access device (VAD) that is being used to deliver medications, as this will affect the results. Established Peripheral Venous Cannulas (PVCs) and below antecubital fossa midlines should not be used for blood sampling. If a TDM sample is taken from a VAD used to administer the medication, ensure this is documented on the request and in the medical notes so this can be considered by laboratory and clinical staff when interpreting results. See Vascular access devices (VADs), care and maintenance guideline for further information.
Record the exact time of all vancomycin samples in the medical notes and ensure the Trakcare sample request form is printed at the time the sample is collected. Both are important to ensure accurate interpretation of vancomycin blood levels. The sample times reported on TrakCare and Clinical Portal are not always accurate.
The target steady state concentration range: 15-25mg/L. If the patient is seriously ill (severe or deep-seated infections), the target range is 20–25mg/L. Close monitoring of renal function is essential due to increased nephrotoxicity risk with this higher target range.
If the patient is failing to respond, seek advice from microbiology or an infection specialist.
Always check that the dosage history and sampling time are appropriate before interpreting the result. Refer to Tables 3 and 4 below and adjust dose accordingly, if required. Seek advice from pharmacy or microbiology if you need help to interpret the result.
If the measured concentration is unexpectedly HIGH or LOW, consider the following: |
|
N.B. Always seek advice if you are unsure or if the current dose is >4000mg daily.
Vancomycin concentration | Suggested dose change |
<10mg/L | Investigate reasons for low concentration, e.g. interruption to infusion, incorrect rate, change in renal function. See table 3. Consider discussing with pharmacy. |
10-<15mg/L | Increase the 12hourly dose by 250mg. |
15-25mg/L |
If the patient is responding to treatment, maintain the present dosage regimen. If the patient is seriously ill, consider increasing the dose amount to achieve a steady state level of 20-25mg/L. Close monitoring of renal function essential due to increased nephrotoxicity risk with this higher target range. If the patient is not responding, discuss with microbiology or infectious diseases. |
26-30mg/L | Decrease the 12hourly dose by 250mg*. |
>30mg/L | Stop until <25mg/L then restart at a lower dose. |
*If the patient is only receiving 500mg/day, reduce the 12hourly dose to 125mg. |
If in doubt, take another sample before modifying the dosage regimen and/or contact pharmacy for advice. |
Guideline reviewed: July 2024
Page updated: August 2024